Amedisys Reports Third Quarter 2018 Financial Results and Updates 2018 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys Reports Third Quarter 2018 Financial Results and Updates 2018 Guidance

Amedisys (AMED) PT Raised to $126 at RBC Capital

October 31, 2018 6:59 AM EDT

RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $126.00 (from $115.00) while maintaining an Outperform rating.

Morgan noted a strong Q3, with momentum in 2019.

... More

Amedisys (AMED) Tops Q3 EPS by 18c, Raises FY Guidance

October 29, 2018 5:02 PM EDT

Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.95, $0.18 better than the analyst estimate of $0.77. Revenue for the quarter came in at $417.3 million versus the consensus estimate of $411.2 million.

GUIDANCE:

Amedisys sees FY2018 EPS of $3.54-$3.60, versus the consensus of $3.40. Amedisys sees... More